Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Betts

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2021
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repairKelly Walton, Kirsti Walker, Megan Riddle, et al.
Blood Cancer Journal|May 19, 2021
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood groupNajla El Jurdi, Heba Elhusseini, Joan Beckman, et al.
JCI Insight|April 8, 2020
Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivityKelly Walton, Mario R Fernandez, Elizabeth M Sagatys, et al.
Frontiers in Immunology|December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor ImmunityBrian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Blood Advances|March 6, 2025
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR AnalysisKarthik Nath, Mei-Jie Zhang, Matthew Bye, et al.
Blood Advances|April 3, 2020
Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G Holtan, Andrea L Hoeschen, Qing Cao, et al.
Blood Advances|April 19, 2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDAaron Etra, Najla El Jurdi, Nikolaos Katsivelos, et al.
Blood|June 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD preventionJoseph A Pidala, Nicoletta Cieri, Michael J Schell, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2021
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repairKelly Walton, Kirsti Walker, Megan Riddle, et al.
Blood Cancer Journal|May 19, 2021
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood groupNajla El Jurdi, Heba Elhusseini, Joan Beckman, et al.
JCI Insight|April 8, 2020
Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivityKelly Walton, Mario R Fernandez, Elizabeth M Sagatys, et al.
Frontiers in Immunology|December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor ImmunityBrian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Blood Advances|March 6, 2025
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR AnalysisKarthik Nath, Mei-Jie Zhang, Matthew Bye, et al.
Blood Advances|April 3, 2020
Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G Holtan, Andrea L Hoeschen, Qing Cao, et al.
Blood Advances|April 19, 2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDAaron Etra, Najla El Jurdi, Nikolaos Katsivelos, et al.
Blood|June 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD preventionJoseph A Pidala, Nicoletta Cieri, Michael J Schell, et al.
Pageof 6